MedTrace Logo

GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management (GLAM-I)

NCT06383494 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 498

Last updated 2026-01-08

No results posted yet for this study

Summary

Patients were randomly assigned to three supraglottic airway devices (SADs) groups for airway management after anesthesia induced. Fiberoptic bronchoscope (FB) guided glottic exposure grading was performed and other airway management quality was recorded.

Conditions

  • Anesthesia
  • Airway Remodeling

Interventions

DEVICE

LMA supreme group

Patient in this group received LMA supreme (one of laryngeal airway management device) for airway management during general anesthesia

DEVICE

I-gel group

Patient in this group received I-gel laryngeal (one of laryngeal airway management device) for airway management during general anesthesia

DEVICE

GMA-Tulip

Patient in this group received GMA-Tulip (one of laryngeal airway management device) for airway management during general anesthesia

Sponsors & Collaborators

  • Zhejiang Cancer Hospital

    lead OTHER

Principal Investigators

  • Jiangling Wang, Ph. D · Zhejiang Cancer Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-30
Primary Completion
2024-12-31
Completion
2025-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06383494 on ClinicalTrials.gov